This includes increased expression of CD80, CD86, MHC I, and MHC II on dendritic cells, elevated levels of CD107 and IFN-γ in CD8+ T cells and NK cells, as well as inhibited expression of molecules related to metastasis and angiogenesis, ultimately inhibiting tumor progression and prolonging survival time (Huang et al., 2021). The gene discussed is CD80; the disease is neoplasm.